Management of Lower Punctal Stenosis.

Status Completed

Clinical Trial Summary

a prospective non-randomized study conducted upon 24 patients with severe lower punctual stenosis (grade 0 according to Kashkouli scale) attending at Menoufia University hospitals. The upper punctum and canaliculus were patent. All patients were complaining of epiphora and had a thorough ophthalmological examination including dye disappearance test, and slit-lamp examination. Pigtail probe was used from patent upper punctum to detect the lower stenosed punctum which was opened with a scalpel. Syringing of the lower lacrimal passages was done to confirm its patency and self retaining silicone bicanalicular stent was inserted. The silicone tube was left in place for 6 months before it was removed. Patients were then followed up for 1 year after the surgery.

Clinical Trial Description

This is a prospective non-randomized study which was conducted upon 24 patients with total lower punctual occlusion attending at Menoufia University hospitals in the period from January 2014 to January 2018. Ethics approval from the institutional review board was obtained, and a written informed consent was taken from every patient according to the Declaration of Helsinki.

All patients of the study were complaining of epiphora and had a thorough ophthalmological examination including dye disappearance test, and slit-lamp examination. The dye disappearance test was performed with a drop of 2% fluorescein sodium and assessment after 5 minutes of the remaining dye in the tear meniscus was done and results were graded.

Surgical procedure

All operations were done under general anesthesia and were performed by two authors (SSM, KES). The authors performed lacrimal probing and syringing test through the normal punctum to exclude concomitant occluded common canaliculus or nasolacrimal duct. The pigtail probe was passed through the canalicular system from the normal punctum to the occluded aspect. When the tip of the pigtail probe was positioned near the occluded punctal area, the surgeon pushed the area to be tented with the pigtail probe. After they advanced the pigtail probe back and forth several times until they could locate the correct position of the occluded punctum, the authors incised the tented area with a scalpel No. 11 to make a new punctal opening.

To ensure punctal and canalicular patency, syringing was repeated through the perforated punctum. To prevent re-occlusion of punctal opening, a self retaining bicanalicular tube (FCI®; Paris, France) was inserted through the normal and perforated puncti.

The silicone tube was left in place for 6 months before it was removed. Patients were then followed up for 1 year after the surgery (6 months after removal of the tube). During the follow-up period, the authors investigated the improvement of subjective epiphora symptoms based on Munk score, fluorescein disappearance test, maintenance of newly formed punctal opening, and incidence of complications. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03731143
Study type	Interventional
Source	Menoufia University
Contact
Status	Completed
Phase	N/A
Start date	January 12, 2014
Completion date	January 12, 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04833452` - Comparative Study Between Wide and Narrow Fenstrum Endoscopic DCR	N/A
Completed	`NCT02240615` - The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora	Phase 0
Suspended	`NCT03705000` - SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction	N/A
Completed	`NCT01010659` - The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora	Phase 4
Recruiting	`NCT05663684` - Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?	Phase 4
Terminated	`NCT04229771` - Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain?	Phase 4
Active, not recruiting	`NCT02849093` - Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.	N/A
Withdrawn	`NCT00824811` - Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel	Phase 2
Completed	`NCT00266838` - Prevention of Docetaxel Induced Dacryostenosis	Phase 1
Active, not recruiting	`NCT04680078` - Placement of Three Interrupted Sutures After Triangular Three-snip Punctoplasty	N/A
Completed	`NCT01282541` - Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora	Phase 2
Completed	`NCT02503956` - Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients	N/A
Completed	`NCT04637633` - Topical Cyclosporine-A for Management of Epiphora	Phase 2/Phase 3
Withdrawn	`NCT03266081` - Bupivacaine Epiphora Trial	Phase 2
Completed	`NCT01766232` - Lacrimal Drainage Resistance Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.